van der Galiën R, Langen A L, Jacobs L J M, Hagen B, Flahive K, Chatterjee S D, van Amsterdam M C
General Electric HealthCare B.V., De Rondom 8, 5612 AP Eindhoven, The Netherlands;
General Electric HealthCare B.V., De Rondom 8, 5612 AP Eindhoven, The Netherlands.
PDA J Pharm Sci Technol. 2023 Jul-Aug;77(4):317-328. doi: 10.5731/pdajpst.2022.012783. Epub 2023 May 15.
A Contamination Control Strategy (CCS) is a document that focuses on how to prevent contaminations with microorganisms, particles, and pyrogens within sterile and/or aseptic and preferably also in nonsterile manufacturing facilities. This document determines to what extent measures and controls in place are efficient in preventing contamination. In order to efficiently evaluate and control all potential hazards associated with sources of contamination within a CCS, the Hazard Analysis Critical Control Point (HACCP) methodology could be a useful tool to monitor all Critical Control Points (CCPs) related to various sources of contamination. This article describes a way to set up the CCS within a pharmaceutical sterile and aseptic manufacturing facility (GE HealthCare Pharmaceutical Diagnostics) by applying the HACCP methodology. In 2021, a global CCS procedure and a general HACCP template became effective for the GE HealthCare Pharmaceutical Diagnostics sites having sterile and/or aseptic manufacturing processes. This procedure guides the sites through the setup of the CCS by applying the HACCP methodology and helps each site to evaluate whether the CCS is still effective taking all (proactive and retrospective) data following the CCS into account. A summary of setting up a CCS using the HACCP methodology, specifically for the pharmaceutical company GE HealthCare Pharmaceutical Diagnostics Eindhoven site, is provided in this article. Use of the HACCP methodology enables a company to include proactive data within the CCS, making use of all identified sources of contamination, associated hazards, and/or control measures and CCPs. The constructed CCS allows the manufacturer to identify whether all included sources of contamination are under control and, if not, which mitigatory actions need to be performed. All current states are reflected by a traffic light color to reflect the level of residual risk, thereby providing a simple and clear visual representation of the current contamination control and microbial state of the manufacturing site.
污染控制策略(CCS)是一份文件,重点关注如何在无菌和/或无菌环境中,最好也在非无菌生产设施中防止微生物、颗粒和热原污染。该文件确定了现有措施和控制在防止污染方面的有效程度。为了在CCS中有效评估和控制与污染源相关的所有潜在危害,危害分析关键控制点(HACCP)方法可能是监测与各种污染源相关的所有关键控制点(CCP)的有用工具。本文介绍了一种通过应用HACCP方法在制药无菌和无菌生产设施(通用电气医疗制药诊断公司)内建立CCS的方法。2021年,全球CCS程序和通用HACCP模板对拥有无菌和/或无菌生产工艺的通用电气医疗制药诊断公司的工厂生效。该程序通过应用HACCP方法指导各工厂建立CCS,并帮助每个工厂在考虑CCS之后的所有(前瞻性和回顾性)数据的情况下评估CCS是否仍然有效。本文提供了使用HACCP方法建立CCS的总结,特别是针对通用电气医疗制药诊断公司埃因霍温工厂。使用HACCP方法使公司能够在CCS中纳入前瞻性数据,利用所有已识别的污染源、相关危害和/或控制措施以及关键控制点。构建的CCS使制造商能够确定所有纳入的污染源是否得到控制,如果没有,则需要采取哪些缓解措施。所有当前状态通过交通信号灯颜色反映,以反映残留风险水平,从而提供制造现场当前污染控制和微生物状态的简单明了的直观表示。